Stroke and Ageing Research, Department of Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, Australia.
Stroke Division, Florey Institute of Neuroscience and Mental Health, University of Melbourne, Heidelberg, Australia.
Trials. 2024 Jan 23;25(1):78. doi: 10.1186/s13063-023-07864-2.
Unplanned hospital presentations may occur post-stroke due to inadequate preparation for transitioning from hospital to home. The Recovery-focused Community support to Avoid readmissions and improve Participation after Stroke (ReCAPS) trial was designed to test the effectiveness of receiving a 12-week, self-management intervention, comprising personalised goal setting with a clinician and aligned educational/motivational electronic messages. Primary outcome is as follows: self-reported unplanned hospital presentations (emergency department/admission) within 90-day post-randomisation. We present the statistical analysis plan for this trial.
METHODS/DESIGN: Participants are randomised 1:1 in variable block sizes, with stratification balancing by age and level of baseline disability. The sample size was 890 participants, calculated to detect a 10% absolute reduction in the proportion of participants reporting unplanned hospital presentations/admissions, with 80% power and 5% significance level (two sided). Recruitment will end in December 2023 when funding is expended, and the sample size achieved will be used. Logistic regression, adjusted for the stratification variables, will be used to determine the effectiveness of the intervention on the primary outcome. Secondary outcomes will be evaluated using appropriate regression models. The primary outcome analysis will be based on intention to treat. A p-value ≤ 0.05 will indicate statistical significance. An independent Data Safety and Monitoring Committee has routinely reviewed the progress and safety of the trial.
This statistical analysis plan ensures transparency in reporting the trial outcomes. ReCAPS trial will provide novel evidence on the effectiveness of a digital health support package post-stroke.
ClinicalTrials.gov ACTRN12618001468213. Registered on August 31, 2018. SAP version 1.13 (October 12 2023) Protocol version 1.12 (October 12, 2022) SAP revisions Nil.
由于从医院过渡到家庭的准备不足,中风后可能会出现计划外的医院就诊。旨在测试接受 12 周自我管理干预措施的有效性,该干预措施包括与临床医生一起制定个性化目标和一致的教育/激励性电子信息。主要结果如下:随机分组后 90 天内自我报告的计划外医院就诊(急诊室/入院)。我们介绍了该试验的统计分析计划。
方法/设计:参与者按 1:1 的比例随机分配到不同的块大小中,按年龄和基线残疾程度分层平衡。样本量为 890 名参与者,计算出该样本量可检测到报告计划外医院就诊/入院的参与者比例降低 10%,效能为 80%,显著性水平为 5%(双侧)。当资金用完时,将于 2023 年 12 月结束招募,届时将使用实现的样本量。将使用调整分层变量的逻辑回归来确定干预对主要结果的有效性。将使用适当的回归模型评估次要结果。主要结果分析将基于意向治疗。p 值≤0.05 表示具有统计学意义。一个独立的数据安全和监测委员会定期审查试验的进展和安全性。
本统计分析计划确保了报告试验结果的透明度。ReCAPS 试验将提供中风后数字健康支持包有效性的新证据。
ClinicalTrials.gov ACTRN12618001468213。注册于 2018 年 8 月 31 日。SAP 版本 1.13(2023 年 10 月 12 日)协议版本 1.12(2022 年 10 月 12 日)SAP 修订无。